A Medical Device Daily Staff Report

Imris (Winnipeg, Manatoba) reported the allowance of a U.S. patent defining the foundational technologies for its Symbis Surgical System , a minimally invasive and MRI-compatible microsurgical robot system.

Currently under development at Imris, the Symbis Surgical System is an image-guided, micro-neurosurgery robot that will combine surgeon-directed robotic arm manipulation with integrated high-definition 3-D anatomical and MR imaging views to enable delicate brain micro-surgery.

The system is being designed to work inside an intraoperative MRI within the Visius Surgical Theatre and provide a virtual extension of the surgeon's hands through robotic instruments with haptic feedback, motion refinement and intricate dexterity for use in the narrow surgical pathways of cranial neurosurgery.

The recently allowed US patent - # 8,396,598 and titled, "Microsurgical Robot System" – is the fifth patent issued related to the Symbis microsurgical system technology, method and concept since development of the product began.

Imris makes image guided therapy solutions.

In other patent news:

• Greenway Medical Technologies (Carrollton, Georgia) has been granted two new U.S. patents related to electronic quality-of-care data liquidity. Both patents cover the receipt and transmission of data from multiple electronic health record (EHR) systems, accessible directly or over the cloud, including data distributed across a vast patient population. Such data liquidity supports improved care coordination, quality, safety and cost-effectiveness.

Patent number 8,428,966 applies to EHR data collected from multiple EHR systems for the purpose of certifications, accreditations and monetary incentives. Patent number 8,438,041 is for similar automation related to tracking clinical events.

• Senior Scientific (Albuquerque, New Mexico), a maker of molecular imaging and nanobiotechnology for the early detection and localization of cancer and other human diseases, said the U.S. Patent Office (USPTO) has issued U.S. Patent No. 8,447,379 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof."

The patent includes claims directed to detecting and measuring biological substances such as cancer cells. The methods can be used in humans, with no harmful radiation, and can find cancers much earlier than is possible with conventional technologies.

No Comments